Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Surgery for extrahepatic cholangiocarcinoma: predictors of survival.

Kloek JJ, Ten Kate FJ, Busch OR, Gouma DJ, van Gulik TM.

HPB (Oxford). 2008;10(3):190-5. doi: 10.1080/13651820801992575.

2.

Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.

Guglielmi A, Ruzzenente A, Campagnaro T, Pachera S, Valdegamberi A, Nicoli P, Cappellani A, Malfermoni G, Iacono C.

World J Surg. 2009 Jun;33(6):1247-54. doi: 10.1007/s00268-009-9970-0.

PMID:
19294467
3.

Prognostic factors in resectable cholangiocarcinoma patients: Carcinoembryonic antigen, lymph node, surgical margin and chemotherapy.

Wirasorn K, Ngamprasertchai T, Chindaprasirt J, Sookprasert A, Khantikaew N, Pakkhem A, Ungarereevittaya P.

World J Gastrointest Oncol. 2013 Apr 15;5(4):81-7. doi: 10.4251/wjgo.v5.i4.81.

4.

Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma.

van der Gaag NA, Kloek JJ, de Bakker JK, Musters B, Geskus RB, Busch OR, Bosma A, Gouma DJ, van Gulik TM.

Ann Oncol. 2012 Oct;23(10):2642-9. Epub 2012 Apr 24.

5.

Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection.

Li T, Qin LX, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Tang ZY, Fan J.

Liver Int. 2014 Jul;34(6):953-60. doi: 10.1111/liv.12364. Epub 2013 Nov 20.

PMID:
24134199
6.

Significance of ductal margin status in patients undergoing surgical resection for extrahepatic cholangiocarcinoma.

Sasaki R, Takeda Y, Funato O, Nitta H, Kawamura H, Uesugi N, Sugai T, Wakabayashi G, Ohkohchi N.

World J Surg. 2007 Sep;31(9):1788-96. Epub 2007 Jul 25.

PMID:
17647056
7.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
8.

[Analysis of the survival in patients after surgical resection of thoracic esophageal cancer].

Zhang HL, Liu RL, Shi YT, Wang ZC, Wang BH, Li YJ, Zhou LY, Ping YM.

Zhonghua Zhong Liu Za Zhi. 2009 Jul;31(7):541-5. Chinese.

PMID:
19950705
9.
10.

Comparison of resection and transarterial chemoembolisation in the treatment of advanced intrahepatic cholangiocarcinoma--a single-center experience.

Scheuermann U, Kaths JM, Heise M, Pitton MB, Weinmann A, Hoppe-Lotichius M, Otto G.

Eur J Surg Oncol. 2013 Jun;39(6):593-600. doi: 10.1016/j.ejso.2013.03.010. Epub 2013 Apr 20.

PMID:
23611755
11.

Pathological confirmation of para-aortic lymph node status as a potential criterion for the selection of intrahepatic cholangiocarcinoma patients for radical resection with regional lymph node dissection.

Nakayama T, Tsuchikawa T, Shichinohe T, Nakamura T, Ebihara Y, Hirano S.

World J Surg. 2014 Jul;38(7):1763-8. doi: 10.1007/s00268-013-2433-7.

PMID:
24378552
12.
13.

Assessment of nodal status for perihilar cholangiocarcinoma: location, number, or ratio of involved nodes.

Aoba T, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y, Nimura Y, Nagino M.

Ann Surg. 2013 Apr;257(4):718-25. doi: 10.1097/SLA.0b013e3182822277.

PMID:
23407295
14.

Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies.

Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, Nakagawa N, Muto T, Sasaki H, Urabe K, Sueda T.

J Gastrointest Surg. 2013 Aug;17(8):1429-39.

PMID:
23797881
15.

The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.

de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, Mega R, Schulick RD, Choti MA, Geller DA, Barroso E, Mentha G, Capussotti L, Pawlik TM.

Cancer. 2012 Oct 1;118(19):4737-47. doi: 10.1002/cncr.27492. Epub 2012 Mar 13.

16.

Cholangiocarcinoma: prognostic factors after surgical resection in China.

Wang Y, Yang H, Shen C, Luo J.

Int J Clin Exp Med. 2015 Apr 15;8(4):5506-12. eCollection 2015.

17.

Correlation between metastatic lymph node ratio and prognosis in patients with extrahepatic cholangiocarcinoma.

Zhang JW, Chu YM, Lan ZM, Tang XL, Chen YT, Wang CF, Che X.

World J Gastroenterol. 2015 Apr 14;21(14):4255-60. doi: 10.3748/wjg.v21.i14.4255.

19.

Prognostic factors in patients with middle and distal bile duct cancers.

Kwon HJ, Kim SG, Chun JM, Lee WK, Hwang YJ.

World J Gastroenterol. 2014 Jun 7;20(21):6658-65. doi: 10.3748/wjg.v20.i21.6658.

20.

The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.

Choi SB, Kim KS, Choi JY, Park SW, Choi JS, Lee WJ, Chung JB.

Ann Surg Oncol. 2009 Nov;16(11):3048-56. doi: 10.1245/s10434-009-0631-1. Epub 2009 Jul 22.

PMID:
19626372
Items per page

Supplemental Content

Write to the Help Desk